Regulus Therapeutics Inc. is a leading biopharmaceutical company specializing in the discovery and development of innovative medicines targeting microRNAs. With a focus on areas such as fibrosis, metabolic diseases, and oncology, Regulus is at the forefront of using RNA-based therapeutics to transform patient care.
